Related Experiment Video

Updated: Aug 9, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Therapy to reduce risk of coronary heart disease

Daniel J Rader1

  • 1Preventive Cardiology and Lipid Clinic, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. rader@mail.med.upenn.edu

Clinical Cardiology
|January 24, 2003
PubMed

Insights

Lowering low-density lipoprotein cholesterol (LDL-C) with statins reduces coronary heart disease (CHD) risk. More aggressive lipid-lowering therapy, including increasing high-density lipoprotein cholesterol (HDL-C), is needed for better patient outcomes.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Statins significantly reduce coronary heart disease (CHD) morbidity and mortality by lowering low-density lipoprotein cholesterol (LDL-C).
  • Many patients with dyslipidemia do not achieve target LDL-C levels, increasing their risk for CHD.
  • Updated guidelines emphasize more aggressive LDL-C reduction for very high-risk patients and highlight the importance of high-density lipoprotein cholesterol (HDL-C).

Purpose of the Study:

  • To review the evidence for more aggressive lipid-lowering strategies in primary and secondary CHD prevention.
  • To discuss the role of increasing HDL-C in addition to lowering LDL-C for improved patient outcomes.
  • To explore the potential of combination therapy and novel statins in managing dyslipidemia.

Main Methods:

  • Review of recent primary and secondary intervention studies.
  • Analysis of updated National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines.
  • Discussion of therapeutic approaches for dyslipidemia management.

Main Results:

  • LDL-C reduction with statins is proven effective in reducing CHD events.
  • Current treatment often fails to meet LDL-C goals in high-risk populations.
  • Higher HDL-C levels are associated with better cardiovascular outcomes.

Conclusions:

  • More aggressive lipid-lowering therapy is necessary for both primary and secondary CHD prevention.
  • Therapies aimed at increasing HDL-C should be considered alongside LDL-C lowering.
  • Combination therapy and next-generation statins may offer enhanced efficacy for dyslipidemia.

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...